Edel Michael J相关文献与解析，生知库 | 链接生命科学的每一步

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

调整脐带血采集和储存标准操作规程，使其适用于HLA纯合诱导多能干细胞的生产和储存以进行临床应用

Alvarez-Palomo, Belén; Vives, Joaquim; Casaroli-Marano, Ricardo P P; G Gomez, Susana G; Rodriguez Gómez, Luciano; Edel, Michael J; Querol Giner, Sergi

细胞生物学

iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use?

iPS细胞技术与遗传不稳定性问题——它能否安全地用于临床？

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm8030288

Attwood, Stephen W; Edel, Michael J

细胞生物学

发表日期：2019

文献求助收藏

Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases.

人类睾丸和精子中表达了两种新型的配体非依赖性 VEGFR-1 受体变体，其中一种能够激活 SRC 原癌基因酪氨酸激酶

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.27232

Alvarez-Palomo Belen, Barrot-Feixat Carme, Sarret Helena, Requena Jordi, Pau Montserrat, Vidal-Taboada Jose-Manuel, Oliva Rafael, Ballesca Josep-Lluis, Edel Michael J, Mezquita-Pla Jovita

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease

生物工程和干细胞技术在先天性心脏病治疗中的应用

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm4040768

Bosman, Alexis; Edel, Michael J; Blue, Gillian; Dilley, Rodney J; Harvey, Richard P; Winlaw, David S

The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases

iPSC衍生疗法在自身免疫性疾病治疗中的潜在未来作用

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm4061193

Hew, Meilyn; O'Connor, Kevin; Edel, Michael J; Lucas, Michaela

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration

利用重编程细胞进行自体治疗黄斑变性的临床应用前景

期刊:

影响因子:

doi:10.1186/s13069-015-0026-9

Alvarez Palomo, Ana Belen; McLenachan, Samuel; Chen, Fred K; Da Cruz, Lyndon; Dilley, Rodney J; Requena, Jordi; Lucas, Michaela; Lucas, Andrew; Drukker, Micha; Edel, Michael J

细胞生物学

发表日期：2015

文献求助收藏

The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation

细胞重编程的力量与前景：个性化自体器官和细胞移植

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm3020373

Palomo, Ana Belen Alvarez; Lucas, Michaela; Dilley, Rodney J; McLenachan, Samuel; Chen, Fred Kuanfu; Requena, Jordi; Sal, Marti Farrera; Lucas, Andrew; Alvarez, Inaki; Jaraquemada, Dolores; Edel, Michael J

Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity

植物激素可提高小鼠体细胞重编程为诱导多能干细胞的效率并降低致瘤性

期刊:

影响因子:

doi:10.1089/scd.2013.0292

Alvarez Palomo, Ana Belén; McLenachan, Samuel; Requena Osete, Jordi; Menchón, Cristina; Barrot, Carme; Chen, Fred; Munné-Bosch, Sergi; Edel, Michael J

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells.

细胞周期蛋白 A1 对于建立多能性状态和降低诱导多能干细胞的致瘤性至关重要

期刊:Stem Cells and Development

影响因子:2

doi:10.1089/scd.2012.0190

McLenachan Samuel, MenchÃ³n Cristina, Raya Angel, Consiglio Antonella, Edel Michael J

Altered genome induced immune response of iPSCs

基因组改变诱导iPSCs的免疫反应

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

调整脐带血采集和储存标准操作规程，使其适用于HLA纯合诱导多能干细胞的生产和储存以进行临床应用

iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use?

iPS细胞技术与遗传不稳定性问题——它能否安全地用于临床？

Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases.

人类睾丸和精子中表达了两种新型的配体非依赖性 VEGFR-1 受体变体，其中一种能够激活 SRC 原癌基因酪氨酸激酶

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease

生物工程和干细胞技术在先天性心脏病治疗中的应用

The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases

iPSC衍生疗法在自身免疫性疾病治疗中的潜在未来作用

Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration

利用重编程细胞进行自体治疗黄斑变性的临床应用前景

The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation

细胞重编程的力量与前景：个性化自体器官和细胞移植

Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity

植物激素可提高小鼠体细胞重编程为诱导多能干细胞的效率并降低致瘤性

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells.

细胞周期蛋白 A1 对于建立多能性状态和降低诱导多能干细胞的致瘤性至关重要